Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IN 10 003 (Accordion Pill Zaleplon) for Insomnia
NCT01196650Phase 2Completed
- Sponsor
- Intec Pharma Ltd.
- Start
- Sep 2010
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of IN 10 003 formulation B in Insomnia (3 arms), sponsored by Intec Pharma Ltd. Primary endpoint: Wake After Sleep Onset. Started Sep 2010; status: completed.
02
Drugs
IN 10 003 formulation B
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT01196650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196650.